ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0199

Pain Phenotypes and Social Determinants of Health in Chronic Chikungunya Arthritis: A Cross-Sectional Study

Abebawork Adem1, Alfonso Sucerquia2, Jose Forero3, Juan Alzate2, Larry Moreland4, Gary Firestein5, Andres Cadena6 and Aileen Chang7, 1George Washington University, Washington, DC, DC, 2The George Washington University, Arlington, 3The George Washington University, Arlington, VA, 4University of Colorado, Denver, CO, 5University of California, San Diego, San Diego, CA, 6Clinica de la Costa, Barranquilla, Colombia, 7The George Washington University, Washington

Meeting: ACR Convergence 2025

Keywords: Arthritis, Infectious, Disability, Disease Activity, Health Assessment Questionnaire (HAQ), pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0199–0209) Infection-related Rheumatic Disease Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Chronic chikungunya arthritis (CCA) is a long-term sequela of chikungunya virus infection marked by persistent pain, disability, and reduced quality of life. While nociplastic, neuropathic and nociceptive pain types have been described in other diseases, they remain understudied in CCA. This study aimed to classify pain phenotypes and evaluate clinical and social determinants associated with each phenotype among individuals with CCA.

Methods: We conducted a cross-sectional analysis of 117 participants enrolled in a clinical trial for CCA in an underserved population. Pain types were categorized using the PainDETECT Questionnaire and the Nociplastic-Based Fibromyalgia Features (NFF) tool. Disease activity and function were assessed using the Chikungunya Disease Activity Score (CHIK-DAS), Disease Activity Score-28 (DAS-28), Health Assessment Questionnaire (HAQ), and arthritis flare score. Social determinants of health (SDOH) were measured using a validated 10-item instrument. Bivariate analyses and multivariable logistic regression were used to examine associations between pain phenotypes and clinical/SDOH variables.

Results: Participants were predominantly female (78.6%), with a median age of 58 years and a median pain duration of 8.6 years. Nociplastic pain was the most prevalent phenotype (79.5%), followed by neuropathic (48.7%) and nociceptive (25.6%) pain. Nociplastic pain was significantly associated with longer pain duration (aOR = 1.02, 95% CI: 1.00–1.04) and sleep disturbance (aOR = 5.27, 95% CI: 1.92–14.44). Neuropathic pain was linked to higher disease activity (aOR = 1.12, 95% CI: 1.03–1.21), sleep disturbance (aOR = 2.47, 95% CI: 1.02–5.96), and medication insecurity (aOR = 4.17, 95% CI: 1.69–10.27). Nociceptive pain was inversely associated with CHIK-DAS (aOR = 0.91, 95% CI: 0.84–0.98) and less frequent among participants with medication insecurity (aOR = 0.33, 95% CI: 0.11–0.96) (Figure 1). Clinical burden was highest in those with nociplastic pain, while social vulnerability was more prominent in those with neuropathic components.

Conclusion: Pain in CCA is multidimensional, with nociplastic and neuropathic phenotypes predominating and associated with greater disease activity and functional impairment. Medication insecurity and sleep disturbance were key predictors of neuropathic pain, while nociplastic pain appeared more driven by chronicity and central sensitization. Incorporating SDOH screening and phenotype-specific assessments like CHIK-DAS may improve pain management strategies in post-viral arthritis.

Supporting image 1Figure 1. Adjusted Odds Ratios (AORs) for Factors Associated with Pain Phenotypes in Chronic Chikungunya Arthritis. Forest plot showing multivariable-adjusted associations between clinical and social factors and the presence of neuropathic, nociceptive, and nociplastic pain components. Odds ratios are plotted on a log scale with 95% confidence intervals. Medication insecurity and higher CHIK-DAS scores were significantly associated with neuropathic pain, while nociplastic pain was linked to longer pain duration and sleep disturbance. Nociceptive pain was inversely associated with CHIK-DAS and medication security risk.


Disclosures: A. Adem: None; A. Sucerquia: None; J. Forero: None; J. Alzate: None; L. Moreland: None; G. Firestein: Eli Lilly, 5; A. Cadena: None; A. Chang: None.

To cite this abstract in AMA style:

Adem A, Sucerquia A, Forero J, Alzate J, Moreland L, Firestein G, Cadena A, Chang A. Pain Phenotypes and Social Determinants of Health in Chronic Chikungunya Arthritis: A Cross-Sectional Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/pain-phenotypes-and-social-determinants-of-health-in-chronic-chikungunya-arthritis-a-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pain-phenotypes-and-social-determinants-of-health-in-chronic-chikungunya-arthritis-a-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology